178 related articles for article (PubMed ID: 23948664)
1. Opposite behavior of plasma levels surfactant protein type B and receptor for advanced glycation end products in pulmonary sarcoidosis.
Magrì D; Mariotta S; Banfi C; Ricotta A; Onofri A; Ricci A; Pisani L; Cauti FM; Ghilardi S; Agostoni P
Respir Med; 2013 Oct; 107(10):1617-24. PubMed ID: 23948664
[TBL] [Abstract][Full Text] [Related]
2. Surfactant-derived proteins as markers of alveolar membrane damage in heart failure.
Gargiulo P; Banfi C; Ghilardi S; Magrì D; Giovannardi M; Bonomi A; Salvioni E; Battaia E; Filardi PP; Tremoli E; Agostoni P
PLoS One; 2014; 9(12):e115030. PubMed ID: 25514679
[TBL] [Abstract][Full Text] [Related]
3. Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure.
Magrì D; Brioschi M; Banfi C; Schmid JP; Palermo P; Contini M; Apostolo A; Bussotti M; Tremoli E; Sciomer S; Cattadori G; Fiorentini C; Agostoni P
Circ Heart Fail; 2009 May; 2(3):175-80. PubMed ID: 19808337
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the modified shuttle walk test and cardiopulmonary exercise test in sarcoidosis.
de Boer S; Kolbe J; Wilsher ML
Respirology; 2014 May; 19(4):604-7. PubMed ID: 24666931
[TBL] [Abstract][Full Text] [Related]
5. Plasma immature form of surfactant protein type B correlates with prognosis in patients with chronic heart failure. A pilot single-center prospective study.
Magrì D; Banfi C; Maruotti A; Farina S; Vignati C; Salvioni E; Morosin M; Brioschi M; Ghilardi S; Tremoli E; Agostoni P
Int J Cardiol; 2015 Dec; 201():394-9. PubMed ID: 26310985
[TBL] [Abstract][Full Text] [Related]
6. Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange.
Lamberto C; Nunes H; Le Toumelin P; Duperron F; Valeyre D; Clerici C
Chest; 2004 Jun; 125(6):2061-8. PubMed ID: 15189922
[TBL] [Abstract][Full Text] [Related]
7. Acute high-altitude exposure reduces lung diffusion: data from the HIGHCARE Alps project.
Agostoni P; Swenson ER; Fumagalli R; Salvioni E; Cattadori G; Farina S; Bussotti M; Tamplenizza M; Lombardi C; Bonacina D; Brioschi M; Caravita S; Modesti P; Revera M; Giuliano A; Meriggi P; Faini A; Bilo G; Banfi C; Parati G
Respir Physiol Neurobiol; 2013 Aug; 188(2):223-8. PubMed ID: 23619193
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of plasma SPB and RAGE during mechanical ventilation in patients undergoing major vascular surgery.
Agostoni P; Banfi C; Magrì D; Vignati C; Doria E; Salvioni E; Moliterni P; Marenzi G; Tremoli E; Sisillo E
Respir Physiol Neurobiol; 2011 Sep; 178(2):256-60. PubMed ID: 21736957
[TBL] [Abstract][Full Text] [Related]
9. Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients?
Marcellis RG; Lenssen AF; de Vries GJ; Baughman RP; van der Grinten CP; Verschakelen JA; De Vries J; Drent M
Lung; 2013 Feb; 191(1):43-52. PubMed ID: 23138855
[TBL] [Abstract][Full Text] [Related]
10. NT-proatrial natriuretic peptide as a possible biomarker of cardiopulmonary involvement in sarcoidosis.
Magrì D; Agostoni P; Ricotta A; Pisani L; Cauti FM; Onofri A; Bruno P; Ricci A; Volpe M; Marchitti S; Mariotta S; Rubattu S
Eur J Intern Med; 2013 Apr; 24(3):278-84. PubMed ID: 23294508
[TBL] [Abstract][Full Text] [Related]
11. Influence of age on manifestation, VC and TLCO values, and bronchoalveolar lavage cell counts of sarcoidosis and extrinsic allergic alveolitis.
Sterclova M; Paluch P; Skibova J; Vasakova M
Clin Respir J; 2015 Jan; 9(1):39-44. PubMed ID: 24406019
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide diffusing capacity and alveolar microvascular recruitment in sarcoidosis.
Phansalkar AR; Hanson CM; Shakir AR; Johnson RL; Hsia CC
Am J Respir Crit Care Med; 2004 May; 169(9):1034-40. PubMed ID: 14977623
[TBL] [Abstract][Full Text] [Related]
13. Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study.
Agostoni P; Banfi C; Brioschi M; Magrì D; Sciomer S; Berna G; Brambillasca C; Marenzi G; Sisillo E
Eur Respir J; 2011 Apr; 37(4):841-7. PubMed ID: 20650982
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET as a predictor of pulmonary function in sarcoidosis.
Keijsers RG; Verzijlbergen EJ; van den Bosch JM; Zanen P; van de Garde EM; Oyen WJ; Grutters JC
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):123-9. PubMed ID: 22117503
[TBL] [Abstract][Full Text] [Related]
15. Plasma surfactant protein-B: a novel biomarker in chronic heart failure.
De Pasquale CG; Arnolda LF; Doyle IR; Aylward PE; Chew DP; Bersten AD
Circulation; 2004 Aug; 110(9):1091-6. PubMed ID: 15302797
[TBL] [Abstract][Full Text] [Related]
16. Sarcoidosis-associated pulmonary hypertension in patients with near-normal lung function.
Maimon N; Salz L; Shershevsky Y; Matveychuk A; Guber A; Shitrit D
Int J Tuberc Lung Dis; 2013 Mar; 17(3):406-11. PubMed ID: 23407231
[TBL] [Abstract][Full Text] [Related]
17. The effects of anesthesia, muscle paralysis, and ventilation on the lung evaluated by lung diffusion for carbon monoxide and pulmonary surfactant protein B.
Di Marco F; Bonacina D; Vassena E; Arisi E; Apostolo A; Banfi C; Centanni S; Agostoni P; Fumagalli R
Anesth Analg; 2015 Feb; 120(2):373-80. PubMed ID: 25360481
[TBL] [Abstract][Full Text] [Related]
18. Is it useful to perform carbon monoxide diffusion capacity and respiratory muscle function tests in patients with multiple sclerosis without disability?
Carvalho SR; Alvarenga Filho H; Papais-Alvarenga RM; Chacur FH; Dias RM
Respirology; 2012 Jul; 17(5):869-75. PubMed ID: 22564062
[TBL] [Abstract][Full Text] [Related]
19. [Ergospirometry in sarcoidosis patients].
Schwaiblmair M; Hettich R; Fruhmann G
Z Kardiol; 1994; 83 Suppl 3():163-8. PubMed ID: 7941666
[TBL] [Abstract][Full Text] [Related]
20. The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis.
Mirsaeidi M; Omar HR; Baughman R; Machado R; Sweiss N
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):317-320. PubMed ID: 28079843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
